
亚太地区经皮机械循环支持设备市场预测至 2027 年 - COVID-19 影响和按产品划分的区域分析(主动脉内球囊泵、VA-体外膜氧合器 (ECMO) 和短期心室辅助设备);最终用户(医院、门诊手术中心等);和国家
No. of Pages: 105 | Report Code: TIPRE00018224 | Category: Life Sciences
No. of Pages: 105 | Report Code: TIPRE00018224 | Category: Life Sciences
页数:105
经皮机械循环支持装置提供了一种有效且快速的方法,可以减缓失代偿性心力衰竭和心源性休克患者血流动力学不稳定的下降趋势,直到患者找到更明确的策略来从这些心脏疾病中恢复过来。疾病。经皮机械循环支持装置的主要作用包括改善自然心输出量、降低心室容积和充盈压、增加冠状动脉灌注、维持重要器官灌注。
亚太地区经皮机械循环支持装置市场预计将从2019年的2.4088亿美元增至2027年的6.8947亿美元。市场预计2019 年至 2027 年复合年增长率将达到 14.4%。 老年人口的增加、心血管疾病患病率的增加以及心脏捐赠者的短缺是预计推动经皮机械循环支持设备市场增长的主要因素亚太地区。然而,在预测期内,市场可能会受到这些设备的高成本以及 COVID-19 大流行对医疗器械行业的影响的影响。
从产品来看,2019年,主动脉内球囊泵(IABP)细分市场占据亚太经皮机械循环支持装置市场的最大份额。就最终用户而言,医院细分市场在 2019 年亚太地区经皮机械循环支持设备市场中占据最大份额。
与亚太地区经皮机械循环支持设备市场报告相关的几个主要主要和次要来源是世界卫生组织 (WHO)、马来西亚医疗旅游理事会、印度政府统计数据、印度品牌资产基金会(IBEF)、 总务省、国家生物技术信息中心(NCBI)、 澳大利亚健康与福利研究所等。 p>
Strategic insights for Asia Pacific Percutaneous Mechanical Circulatory Support Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 240.88 Million |
Market Size by 2027 | US$ 689.47 Million |
Global CAGR (2019 - 2027) | 14.4% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Percutaneous Mechanical Circulatory Support Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market is valued at US$ 240.88 Million in 2019, it is projected to reach US$ 689.47 Million by 2027.
As per our report Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market, the market size is valued at US$ 240.88 Million in 2019, projecting it to reach US$ 689.47 Million by 2027. This translates to a CAGR of approximately 14.4% during the forecast period.
The Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market report:
The Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Percutaneous Mechanical Circulatory Support Devices Market value chain can benefit from the information contained in a comprehensive market report.